439 related articles for article (PubMed ID: 17198263)
1. Predictors of disease recurrence following neoadjuvant chemoradiotherapy and liver transplantation for unresectable perihilar cholangiocarcinoma.
Heimbach JK; Gores GJ; Haddock MG; Alberts SR; Pedersen R; Kremers W; Nyberg SL; Ishitani MB; Rosen CB
Transplantation; 2006 Dec; 82(12):1703-7. PubMed ID: 17198263
[TBL] [Abstract][Full Text] [Related]
2. Vascular complications after orthotopic liver transplantation after neoadjuvant therapy for hilar cholangiocarcinoma.
Mantel HT; Rosen CB; Heimbach JK; Nyberg SL; Ishitani MB; Andrews JC; McKusick MA; Haddock MG; Alberts SR; Gores GJ
Liver Transpl; 2007 Oct; 13(10):1372-81. PubMed ID: 17427173
[TBL] [Abstract][Full Text] [Related]
3. Impact of neoadjuvant chemoradiation on the tumor burden before liver transplantation for unresectable cholangiocarcinoma.
Panjala C; Nguyen JH; Al-Hajjaj AN; Rosser BA; Nakhleh RE; Bridges MD; Ko SJ; Buskirk SJ; Kim GP; Harnois DM
Liver Transpl; 2012 May; 18(5):594-601. PubMed ID: 22140024
[TBL] [Abstract][Full Text] [Related]
4. Neoadjuvant chemoradiotherapy followed by liver transplantation for unresectable cholangiocarcinoma: a single-centre national experience.
Duignan S; Maguire D; Ravichand CS; Geoghegan J; Hoti E; Fennelly D; Armstrong J; Rock K; Mohan H; Traynor O
HPB (Oxford); 2014 Jan; 16(1):91-8. PubMed ID: 23600750
[TBL] [Abstract][Full Text] [Related]
5. Liver transplantation for unresectable perihilar cholangiocarcinoma.
Heimbach JK; Gores GJ; Haddock MG; Alberts SR; Nyberg SL; Ishitani MB; Rosen CB
Semin Liver Dis; 2004 May; 24(2):201-7. PubMed ID: 15192792
[TBL] [Abstract][Full Text] [Related]
6. Liver transplant for hepatocellular carcinoma: experience in a Saudi population.
Allam N; Khalaf H; Fagih M; Al-Sebayel M
Exp Clin Transplant; 2008 Mar; 6(1):14-24. PubMed ID: 18405240
[TBL] [Abstract][Full Text] [Related]
7. Long-term, tumor-free survival after radiotherapy combining hepatectomy-Whipple en bloc and orthotopic liver transplantation for early-stage hilar cholangiocarcinoma.
Wu Y; Johlin FC; Rayhill SC; Jensen CS; Xie J; Cohen MB; Mitros FA
Liver Transpl; 2008 Mar; 14(3):279-86. PubMed ID: 18306329
[TBL] [Abstract][Full Text] [Related]
8. Surgical treatments and prognoses of patients with combined hepatocellular carcinoma and cholangiocarcinoma.
Kim KH; Lee SG; Park EH; Hwang S; Ahn CS; Moon DB; Ha TY; Song GW; Jung DH; Kim KM; Lim YS; Lee HC; Chung YH; Lee YS; Suh DJ
Ann Surg Oncol; 2009 Mar; 16(3):623-9. PubMed ID: 19130133
[TBL] [Abstract][Full Text] [Related]
9. Precancerous bile duct pathology in end-stage primary sclerosing cholangitis, with and without cholangiocarcinoma.
Lewis JT; Talwalkar JA; Rosen CB; Smyrk TC; Abraham SC
Am J Surg Pathol; 2010 Jan; 34(1):27-34. PubMed ID: 19898228
[TBL] [Abstract][Full Text] [Related]
10. Resection of hilar cholangiocarcinoma: concomitant liver resection decreases hepatic recurrence.
Ito F; Agni R; Rettammel RJ; Been MJ; Cho CS; Mahvi DM; Rikkers LF; Weber SM
Ann Surg; 2008 Aug; 248(2):273-9. PubMed ID: 18650638
[TBL] [Abstract][Full Text] [Related]
11. [Long-term, tumor-free survival after radiotherapy combining hepatectomy-Whipple en bloc and orthotopic liver transplantation for early-stage hilar cholangiocarcinoma].
Wu YM; Johlin FC; Rayhill SC; Jensen CS; Jin X; Mitros FA
Zhonghua Wai Ke Za Zhi; 2009 Aug; 47(15):1155-61. PubMed ID: 20021907
[TBL] [Abstract][Full Text] [Related]
12. Downstaging Locally Advanced Cholangiocarcinoma Pre-Liver Transplantation: A Prospective Pilot Study.
Wong M; Kim J; George B; Eriksen C; Pearson T; Robbins J; Zimmerman MA; Hong JC
J Surg Res; 2019 Oct; 242():23-30. PubMed ID: 31059945
[TBL] [Abstract][Full Text] [Related]
13. Orthotopic liver transplantation in combination with neoadjuvant therapy: a new paradigm in the treatment of unresectable intrahepatic cholangiocarcinoma.
Rana A; Hong JC
Curr Opin Gastroenterol; 2012 May; 28(3):258-65. PubMed ID: 22333563
[TBL] [Abstract][Full Text] [Related]
14. Liver transplantation in precirrhotic biliary tract disease: Portal hypertension is frequently associated with nodular regenerative hyperplasia and obliterative portal venopathy.
Abraham SC; Kamath PS; Eghtesad B; Demetris AJ; Krasinskas AM
Am J Surg Pathol; 2006 Nov; 30(11):1454-61. PubMed ID: 17063088
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and risk factors for gallbladder neoplasia in patients with primary sclerosing cholangitis: evidence for a metaplasia-dysplasia-carcinoma sequence.
Lewis JT; Talwalkar JA; Rosen CB; Smyrk TC; Abraham SC
Am J Surg Pathol; 2007 Jun; 31(6):907-13. PubMed ID: 17527079
[TBL] [Abstract][Full Text] [Related]
16. Predictive index for tumor recurrence after liver transplantation for locally advanced intrahepatic and hilar cholangiocarcinoma.
Hong JC; Petrowsky H; Kaldas FM; Farmer DG; Durazo FA; Finn RS; Saab S; Han SH; Lee P; Markovic D; Lassman C; Hiatt JR; Busuttil RW
J Am Coll Surg; 2011 Apr; 212(4):514-20; discussion 520-1. PubMed ID: 21463781
[TBL] [Abstract][Full Text] [Related]
17. Successful liver transplantation for hilar cholangiocarcinoma.
Heimbach JK
Curr Opin Gastroenterol; 2008 May; 24(3):384-8. PubMed ID: 18408469
[TBL] [Abstract][Full Text] [Related]
18. Prolonged disease-free survival after orthotopic liver transplantation plus adjuvant chemoirradiation for cholangiocarcinoma.
De Vreede I; Steers JL; Burch PA; Rosen CB; Gunderson LL; Haddock MG; Burgart L; Gores GJ
Liver Transpl; 2000 May; 6(3):309-16. PubMed ID: 10827231
[TBL] [Abstract][Full Text] [Related]
19. Neoadjuvant therapy and liver transplantation for hilar cholangiocarcinoma: is pretreatment pathological confirmation of diagnosis necessary?
Rosen CB; Darwish Murad S; Heimbach JK; Nyberg SL; Nagorney DM; Gores GJ
J Am Coll Surg; 2012 Jul; 215(1):31-8; discussion 38-40. PubMed ID: 22621893
[TBL] [Abstract][Full Text] [Related]
20. Liver transplantation for cholangiocarcinoma.
Schwartz JJ; Hutson WR; Gayowski TJ; Sorensen JB
Transplantation; 2009 Aug; 88(3):295-8. PubMed ID: 19667927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
